MINAPHARM Pharmaceuticals (EGX: MIPH)

MINAPHARM Pharmaceuticals Revenue

MINAPHARM Pharmaceuticals had revenue of 1.08B EGP in the quarter ending June 30, 2024, with 1.12% growth. This brings the company's revenue in the last twelve months to 3.92B, down -2.18% year-over-year. In the year 2023, MINAPHARM Pharmaceuticals had annual revenue of 3.89B with 7.50% growth.

• Revenue (ttm): 3.92B
• Revenue Growth: -2.18%
• P/S Ratio: 0.44
• Revenue / Employee: 8.70M
• Employees: 450
• Market Cap: 1.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.89B	271.51M	7.50%
Dec 31, 2022	3.62B	615.19M	20.47%
Dec 31, 2021	3.01B	644.34M	27.29%
Dec 31, 2020	2.36B	309.95M	15.11%
Dec 31, 2019	2.05B	132.13M	6.89%